Hexima Limited Price Chart
Hexima Limited HXL.XA Financial and Trading Overview
| Hexima Limited stock price | 0.01 AUD |
| Previous Close | 0.01 AUD |
| Open | 0.01 AUD |
| Bid | 0.01 AUD x N/A |
| Ask | 0 AUD x N/A |
| Day's Range | 0.01 - 0.01 AUD |
| 52 Week Range | 0.01 - 0.08 AUD |
| Volume | 100.6K AUD |
| Avg. Volume | 85.59K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.65718 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HXL.XA Valuation Measures
| Enterprise Value | -288696 AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.89473695 |
| Enterprise Value/Revenue | -0.06 |
| Enterprise Value/EBITDA | 0.039 |
Trading Information
Hexima Limited Stock Price History
| Beta (5Y Monthly) | 0.65718 |
| 52-Week Change | -68.88% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.08 AUD |
| 52 Week Low | 0.01 AUD |
| 50-Day Moving Average | 0.02 AUD |
| 200-Day Moving Average | 0.02 AUD |
HXL.XA Share Statistics
| Avg. Volume (3 month) | 85.59K AUD |
| Avg. Daily Volume (10-Days) | 104.83K AUD |
| Shares Outstanding | N/A |
| Float | 72.03M |
| Short Ratio | N/A |
| % Held by Insiders | 44.93% |
| % Held by Institutions | 10.55% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -156.090% |
| Operating Margin (ttm) | -153.78% |
| Gross Margin | 96.35% |
| EBITDA Margin | -152.10% |
Management Effectiveness
| Return on Assets (ttm) | -45.55% |
| Return on Equity (ttm) | -118.094% |
Income Statement
| Revenue (ttm) | 4.82M AUD |
| Revenue Per Share (ttm) | 0.03 AUD |
| Quarterly Revenue Growth (yoy) | -42.29% |
| Gross Profit (ttm) | 5.45M AUD |
| EBITDA | -7326995 AUD |
| Net Income Avi to Common (ttm) | -7519166 AUD |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.63M AUD |
| Total Cash Per Share (mrq) | 0.02 AUD |
| Total Debt (mrq) | 0 AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.679 |
| Book Value Per Share (mrq) | 0.019 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9340325 AUD |
| Levered Free Cash Flow (ttm) | -8097137 AUD |
Profile of Hexima Limited
| Country | Australia |
| State | VIC |
| City | Preston |
| Address | Corporate One |
| ZIP | 3072 |
| Phone | 61 3 9479 1210 |
| Website | https://www.hexima.com.au |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is the plant defensin, pezadeftide, which is in phase IIb clinical trials for the treatment of fungal toenail infections in Australia and New Zealand. Hexima Limited was incorporated in 1997 and is based in Preston, Australia.
Q&A For Hexima Limited Stock
What is a current HXL.XA stock price?
Hexima Limited HXL.XA stock price today per share is 0.01 AUD.
How to purchase Hexima Limited stock?
You can buy HXL.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hexima Limited?
The stock symbol or ticker of Hexima Limited is HXL.XA.
How many shares does Hexima Limited have in circulation?
The max supply of Hexima Limited shares is 0.
What is Hexima Limited Price to Earnings Ratio (PE Ratio)?
Hexima Limited PE Ratio is now.
What was Hexima Limited earnings per share over the trailing 12 months (TTM)?
Hexima Limited EPS is 0 AUD over the trailing 12 months.